2026-07-28T14:33:10Zhttps://docta.ucm.es/rest/oai/request

oai:docta.ucm.es:20.500.14352/1073172025-03-18T15:02:12Zcom_20.500.14352_14col_20.500.14352_15

Huntley, Dixie Giménez, Estela Pascual, María Jesús Vázquez, Lourdes Amat, Paula Remigia, María José Hernández Martín, Marta María Hernández Boluda, Juan Carlos Gago, Beatriz Piñana, José Luis García, Magdalena Pérez, Ariadna Alberola, Juan Gozalbo Rovira, Roberto Albert, Eliseo Solano, Carlos Navarro, David 2024-07-31T11:50:14Z 2024-07-31T11:50:14Z 2020-05-23 Huntley, D., Giménez, E., Pascual, M.J. et al. Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide. Bone Marrow Transplant 55, 1493–1496 (2020). https://doi.org/10.1038/s41409-020-0950-1 0268-3369 1476-5365 10.1038/s41409-020-0950-1 https://hdl.handle.net/20.500.14352/107317 https://doi.org/10.1038/s41409-020-0950-1 https://www.nature.com/bmt/ Cytomegalovirus (CMV) DNAemia remains a clinically relevant problem following allogeneic stem cell transplantation (allo-HSCT). Currently, enumeration of IFN-γ- producing CMV-specific T cells provides helpful yet improvable data for patient stratification for risk of primary or recurrent CMV DNAemia and for predicting clinically refractory episodes of CMV DNAemia. eng http://creativecommons.org/licenses/by-nc-nd/4.0/ metadata only access Attribution-NonCommercial-NoDerivatives 4.0 International Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide journal article